Biotrial Central Laboratory to Exhibit at 2nd Annual Safety Pharmacology World Europe Conference in London

Share Article

Biotrial, a highly recognized specialist of QT studies and provider of central ECG and imaging services, will be exhibiting at the 2nd Annual Safety Pharmacology World Europe Conference (http://www.terrapinn.com) in London (October 28-30, 2008).

Biotrial, a highly recognized specialist of QT studies and provider of central ECG and imaging services, will be exhibiting at the 2nd Annual Safety Pharmacology World Europe Conference (http://www.terrapinn.com) in London (October 28-30, 2008).

"It is a perfect time to exhibit at the 2nd Annual Safety Pharmacology World Europe conference," said Philippe L'Hostis, Managing Director of the Central ECG and Imaging Laboratory at Biotrial. "We provide an integrated solution for collecting, managing, and analysing cardiac safety as well as medical imaging data. Our unique IFA Commitment: Integrity of data delivered, Flexibility of the organization and Adaptability to the ever changing technological and regulatory environment, has made Biotrial an increasingly recognized name in this field. We're looking forward to having the opportunity of meeting with additional sponsors and show them how we can significantly help optimize their clinical trial".

Jean-Marc Gandon, Biotrial CEO, commented: "We are pleased to be exhibiting at this conference, which will gather key safety pharmacology professionals globally to address the scientific and regulatory challenges in QT analysis and reporting. Over the years, Biotrial has developed a highly recognized expertise in QT studies, whether we perform the clinical aspect in-house or not. Our ECG Central Laboratory is well-known worldwide for its performance in this area."

Biotrial will be exhibiting at Booth #5 throughout the conference at The Hilton London Euston hotel.

About Biotrial:
Founded in 1989 by Jean-Marc Gandon, PharmD, (President & CEO), Biotrial (http://www.biotrial.com) is an independent and privately owned CRO.
With 150 beds and a staff of 250 in several subsidiaries in France and the UK, Biotrial runs over 80 studies per year, either in their own clinics in Paris and Rennes, or in cooperation with hospital specialists and general practitioners.

With a large range of services from Phase I studies, Clinical Trial Management Phase II-IV, Oncology, Data Management, Biostatistics, Central Labs (ECG, Imaging), Medical Writing, Non-Clinical Pharmacology, QA & advice in Regulatory Affairs, Biotrial can manage every step of your development process.

For further information please contact Anne Peron at [+33] (0)2 99 599 191 or visit http://www.biotrial.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Allison Kinnucan
Biotrial
33 (0)2 99 59 91 91
Email >